{"componentChunkName":"component---src-templates-topic-topic-tsx","path":"/topics/meibomian-cyst-chalazion/","result":{"data":{"firstChapter":{"id":"ce380c6e-3d94-5ad4-a8b6-9fe46e833a6a","slug":"summary","fullItemName":"Summary","subChapters":[],"depth":1,"htmlHeader":"<!-- begin field 0303da9e-ad4b-4ce6-a11b-d785459ae35d --><h1>Meibomian cyst (chalazion): Summary</h1><!-- end field 0303da9e-ad4b-4ce6-a11b-d785459ae35d -->","htmlStringContent":"<!-- begin item 1fb234ab-5e5a-4c29-9d37-258b10a08694 --><!-- begin field 23334085-c6ad-4a0b-a5a7-708fc1c4de26 --><ul><li>A meibomian cyst (also known as a chalazion) is a sterile, chronic, inflammatory granuloma of the eyelid caused by a foreign body reaction to sebum within a meibomian gland.</li><li>Meibomian cysts can occur in all age groups (but are thought to be most common in adults) and are a frequent cause of lumps in the eyelid. </li><li>Pregnant women and people with the following conditions are more at risk of meibomium cysts (and their recurrence):<ul><li>Blepharitis.</li><li>Seborrhoeic dermatitis.</li><li>Rosacea.</li><li>Diabetes mellitus.</li><li>Elevated serum cholesterol.</li></ul></li><li>A meibomian cyst rarely causes serious complications.</li><li>A meibomian cyst typically presents as a firm, painless, localized eyelid swelling that develops slowly over several weeks. <ul><li>Cysts are more common on the upper than the lower eyelid.</li><li>They are usually 2–8 mm in diameter.</li><li>One or both eyes can be affected.</li><li>More than one meibomian cyst may be present.</li><li>When the eyelid is everted, there is a discrete, immobile nodule (granuloma).</li></ul></li><li>Management of meibomian cyst involves the application of a warm compress (for example, using a clean flannel that has been rinsed with hot water) to the affected eye for 10–15 minutes, after which the cyst should be gently massaged (to aid expression of its contents) in the direction of the eyelashes using clean fingers or cotton buds. This should be repeated up to five times a day for several weeks.<ul><li>Antibiotic treatment is not recommended for meibomian cyst.</li><li>Management of any co-existing risk factors may reduce the risk of recurrence.</li></ul></li><li>Hospital admission is required if there are symptoms and signs of significant periorbital or orbital cellulitis. Both may present acutely with a firm, warm, tender, erythematous, oedematous eyelid.</li><li>An urgent referral should be made if a malignant eyelid tumour is suspected (for example if a lesion has an ulcerated or atypical appearance, or recurs in the same location).</li><li>Referral to an ophthalmologist should be made if the meibomian cyst is affecting vision, causing discomfort (especially if it is large and hard), is cosmetically unacceptable, or if there is no response to conservative treatment.</li></ul><!-- end field 23334085-c6ad-4a0b-a5a7-708fc1c4de26 --><!-- end item 1fb234ab-5e5a-4c29-9d37-258b10a08694 -->","topic":{"id":"b8ad70ad-fd63-54ad-95ce-9cb01a976077","topicId":"83b169c9-dca7-4b48-8c2f-5f840191325e","topicName":"Meibomian cyst (chalazion)","slug":"meibomian-cyst-chalazion","aliases":["Chalazion (meibomian cyst)"],"chapters":[{"id":"ce380c6e-3d94-5ad4-a8b6-9fe46e833a6a","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"31b10667-6c79-5777-8a90-23262ca3b05d","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"45562bbf-dae7-50e1-982d-169c7e5c5538","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"51d7c48d-7e9b-59e0-9b26-056775bc8460","slug":"changes","fullItemName":"Changes"},{"id":"baa47239-625b-5db6-aae4-00668289dfec","slug":"update","fullItemName":"Update"}]},{"id":"fa120f5b-00af-53fd-9552-689fe5dc905d","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"40c525e8-09c0-58c3-aa44-5d21fd56e913","slug":"goals","fullItemName":"Goals"},{"id":"77b51ca3-1111-519c-b74d-cd6f06191e87","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"438e6692-f79d-5661-8c6a-8820daa7481b","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"4b2c99a6-a203-55cf-9968-1e25119a9a02","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"dc892b82-91f1-5a2e-b455-3e128b9c7953","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"07c20e54-7eb8-532e-a9b9-8f4932b1eeab","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"380aae4d-a20e-5643-8b48-5841b3d1eb26","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"70db5497-1bf4-5e7f-9049-2cc54bb758c1","slug":"definition","fullItemName":"Definition"},{"id":"f4fa1377-fc7b-5d61-9c81-12b9a566c573","slug":"prevalence","fullItemName":"Prevalence"},{"id":"8be72264-aa79-5dfc-b028-5e4ec3d4a130","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"75ef5189-b75a-582c-a171-a591d8b4a22b","slug":"prognosis","fullItemName":"Prognosis"},{"id":"1100f706-7196-56a3-8f7b-08f8fb708eaa","slug":"complications","fullItemName":"Complications"}]},{"id":"09b5aa35-8ce9-5ef0-ad8c-8a271452dbcb","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"f6e6a824-264a-52f6-9745-8346a1de5019","slug":"diagnosis","fullItemName":"Diagnosis"}]},{"id":"5da4268d-1aed-5614-bcff-2c4e7c7ef0ae","slug":"management","fullItemName":"Management","subChapters":[{"id":"828f7d50-efa1-585d-aebe-1f64052007aa","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"90dde465-544a-5aa5-8a28-7a884db8e28c","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"dcf4042f-9b4d-522d-88ff-e660b5be6702","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"d221ae7c-d731-5874-a2c3-55710d9f3579","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"4bf0f9c5-61cf-5b7b-815b-1607ee9da389","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"0460285c-6b58-5743-a4e7-c0e7b7be9e5b","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"bd31369e-2482-5af3-8f7d-2036152bf417","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"5899d820-151b-5e22-b6f1-a318f70a0565","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"fc2e5a3f-abe6-572f-91b0-fc070b08be31","slug":"references","fullItemName":"References","subChapters":[]}]}},"topic":{"id":"b8ad70ad-fd63-54ad-95ce-9cb01a976077","topicId":"83b169c9-dca7-4b48-8c2f-5f840191325e","topicName":"Meibomian cyst (chalazion)","slug":"meibomian-cyst-chalazion","aliases":["Chalazion (meibomian cyst)"],"topicSummary":"A meibomian cyst (also known as a chalazion) is a sterile, chronic, inflammatory granuloma caused by the obstruction of a meibomian gland.","lastRevised":"Last revised in August 2020","nextPlannedReviewBy":"2024-03-01T00:00:00+00:00","nextPlannedReviewByDateTime":"2024-03","nextPlannedReviewByDisplay":"March 2024","specialities":[{"id":"485bdd1b-4437-5374-838e-f1f1db61a424","name":"Eyes","slug":"eyes"}],"chapters":[{"id":"ce380c6e-3d94-5ad4-a8b6-9fe46e833a6a","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"31b10667-6c79-5777-8a90-23262ca3b05d","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"45562bbf-dae7-50e1-982d-169c7e5c5538","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"51d7c48d-7e9b-59e0-9b26-056775bc8460","slug":"changes","fullItemName":"Changes"},{"id":"baa47239-625b-5db6-aae4-00668289dfec","slug":"update","fullItemName":"Update"}]},{"id":"fa120f5b-00af-53fd-9552-689fe5dc905d","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"40c525e8-09c0-58c3-aa44-5d21fd56e913","slug":"goals","fullItemName":"Goals"},{"id":"77b51ca3-1111-519c-b74d-cd6f06191e87","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"438e6692-f79d-5661-8c6a-8820daa7481b","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"4b2c99a6-a203-55cf-9968-1e25119a9a02","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"dc892b82-91f1-5a2e-b455-3e128b9c7953","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"07c20e54-7eb8-532e-a9b9-8f4932b1eeab","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"380aae4d-a20e-5643-8b48-5841b3d1eb26","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"70db5497-1bf4-5e7f-9049-2cc54bb758c1","slug":"definition","fullItemName":"Definition"},{"id":"f4fa1377-fc7b-5d61-9c81-12b9a566c573","slug":"prevalence","fullItemName":"Prevalence"},{"id":"8be72264-aa79-5dfc-b028-5e4ec3d4a130","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"75ef5189-b75a-582c-a171-a591d8b4a22b","slug":"prognosis","fullItemName":"Prognosis"},{"id":"1100f706-7196-56a3-8f7b-08f8fb708eaa","slug":"complications","fullItemName":"Complications"}]},{"id":"09b5aa35-8ce9-5ef0-ad8c-8a271452dbcb","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"f6e6a824-264a-52f6-9745-8346a1de5019","slug":"diagnosis","fullItemName":"Diagnosis"}]},{"id":"5da4268d-1aed-5614-bcff-2c4e7c7ef0ae","slug":"management","fullItemName":"Management","subChapters":[{"id":"828f7d50-efa1-585d-aebe-1f64052007aa","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"90dde465-544a-5aa5-8a28-7a884db8e28c","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"dcf4042f-9b4d-522d-88ff-e660b5be6702","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"d221ae7c-d731-5874-a2c3-55710d9f3579","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"4bf0f9c5-61cf-5b7b-815b-1607ee9da389","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"0460285c-6b58-5743-a4e7-c0e7b7be9e5b","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"bd31369e-2482-5af3-8f7d-2036152bf417","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"5899d820-151b-5e22-b6f1-a318f70a0565","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"fc2e5a3f-abe6-572f-91b0-fc070b08be31","slug":"references","fullItemName":"References","subChapters":[]}]}},"pageContext":{"id":"b8ad70ad-fd63-54ad-95ce-9cb01a976077"}},"staticQueryHashes":["3666801979"]}